Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review
Authors
Keywords
Artemether-lumefantrine, Adverse event, Paediatrics, Children, Safety
Journal
MALARIA JOURNAL
Volume 12, Issue 1, Pages 385
Publisher
Springer Nature
Online
2013-11-01
DOI
10.1186/1475-2875-12-385
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria
- (2012) Carine Van Malderen et al. MALARIA JOURNAL
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map
- (2012) Rosalind E. Howes et al. PLOS MEDICINE
- Therapeutic Efficacy and Effects of Artemether-Lumefantrine and Artesunate-Amodiaquine Coformulated or Copackaged on Malaria-Associated Anemia in Children with Uncomplicated Plasmodium falciparum Malaria in Southwest Nigeria
- (2011) Grace O. Gbotosho et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data
- (2011) Patricia Schlagenhauf et al. MALARIA JOURNAL
- Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children
- (2011) Michael Nambozi et al. MALARIA JOURNAL
- Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kouté, Côte d’Ivoire
- (2011) Offianan A. Toure et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial
- (2011) PLOS MEDICINE
- Increased Risk of Early Vomiting among Infants and Young Children Treated with Dihydroartemisinin-Piperaquine Compared with Artemether-Lumefantrine for Uncomplicated Malaria
- (2010) Darren Creek et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A Randomized Trial of Artesunate Mefloquine versus Artemether Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Senegalese Children
- (2010) Babacar Faye et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Low quality of reporting adverse drug reactions in paediatric randomised controlled trials
- (2010) T. W. de Vries et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Early variations in Plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance
- (2010) Obaro S Michael et al. MALARIA JOURNAL
- High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria
- (2010) C. O. Falade et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Azithromycin plus Artesunate versus Artemether‐Lumefantrine for Treatment of Uncomplicated Malaria in Tanzanian Children: A Randomized, Controlled Trial
- (2009) Alma Sykes et al. CLINICAL INFECTIOUS DISEASES
- Artemether‐Lumefantrine versus Dihydroartemisinin‐Piperaquine for Falciparum Malaria: A Longitudinal, Randomized Trial in Young Ugandan Children
- (2009) Emmanuel Arinaitwe et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Sulfadoxine‐Pyrimethamine, Unsupervised Artemether‐Lumefantrine, and Unsupervised Artesunate‐Amodiaquine Fixed‐Dose Formulation for UncomplicatedPlasmodium falciparumMalaria in Benin: A Randomized Effectiveness Noninferiority Trial
- (2009) Jean‐François Faucher et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
- (2009) Shereen Katrak et al. MALARIA JOURNAL
- Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
- (2009) Zul Premji et al. PLoS One
- Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial
- (2009) Quique Bassat et al. PLoS One
- A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children
- (2008) Robin Kobbe et al. MALARIA JOURNAL
- Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children
- (2008) Catherine Maiteki-Sebuguzi et al. MALARIA JOURNAL
- Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up
- (2008) George O Adjei et al. MALARIA JOURNAL
- Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria
- (2008) Philip U Agomo et al. MALARIA JOURNAL
- A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
- (2008) Petra F Mens et al. MALARIA JOURNAL
- A Trial of Combination Antimalarial Therapies in Children from Papua New Guinea
- (2008) Harin A. Karunajeewa et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started